Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis - Wikidata - awgldk - TriplyDB

Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis

Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis

http://www.wikidata.org/entity/Q55981835

about

Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change.Diffuse Cystic Lung Disease. Part I.Diffuse Cystic Lung Disease. Part II.Lymphangioleiomyomatosis: an explosive presentation of a rare disease.Involvement of lymphatics in lymphangioleiomyomatosis TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.Unusual causes of pneumothorax Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.The prevalence of acute response to bronchodilator in pulmonary lymphangioleiomyomatosis.Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells.Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosis Lymphangioleiomyomatosis: what do we know and what are we looking for?Lymphatic involvement in lymphangioleiomyomatosis Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex.Doxycycline reduces the migration of tuberous sclerosis complex-2 null cells - effects on RhoA-GTPase and focal adhesion kinase.Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans Lymphangioleiomyomatosis - a wolf in sheep's clothing.Lymphangioleiomyomatosis: current and future.Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis.A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options.Tuberous sclerosis complex: Recent advances in manifestations and therapy.Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis.Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.Association of lymphangioleiomyomatosis (LAM) with endosalpingiosis in the retroperitoneal lymph nodes: report of two cases.The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

P2860

Q33233774-C903F18D-1E64-4215-8560-46E5DAF1622A Q33339615-E250CED9-BF98-48FE-A1A4-7CD36EF6BA55 Q33722950-ADB180D4-F638-4371-98EF-252229268CAE Q33735622-7EC92909-9E75-489A-9A5F-A69FD4A4021E Q33770723-924C3380-83FC-4DC6-80F6-E8769E642749 Q33905141-9F57ECA2-4D22-4201-8FA0-B3457B515A29 Q33991599-183972FC-B421-48F5-A8B6-36C2C077348E Q34161676-CA3C82BD-D968-4F70-A350-ABA3A198594E Q34374170-4254D808-8B52-4327-BCD2-05614F836127 Q34375358-10A10D07-2B8D-4DAE-A648-17DE55C6628F Q34408059-1E36A253-2F8F-4D0D-B97F-EE5170C6FC25 Q34465125-DAAE2D22-4FF9-4970-B460-DE12A5BF7A2D Q34536450-09215EBD-7ABC-4491-B4A7-DD1C7AF75CC0 Q34560457-9B578313-0394-40C2-80D1-E4D4B99D487B Q34594397-C64CF014-32F4-48F5-A2FC-6705CFDAC37F Q35107703-D4473BE4-540A-4FC7-9443-0CD4F86E7579 Q35140982-72454A81-4A07-4F1E-932D-13BF992B4560 Q35210027-10C9FD78-74AC-4C83-B497-D3D7D3CCBA79 Q35610828-F8A00D57-58AE-48AB-BB99-4631B5024E4D Q36067383-D3ABC502-3B4C-4581-9F7F-8501918F141B Q36083291-8EDE964D-B136-4069-A46A-CB750D367EAE Q36210035-34FFCD69-4314-44CC-8DD3-4A7CA7CE4A25 Q36232850-F449C38B-A837-4190-9A1A-29FC9562E205 Q36330644-0018DB38-A301-440F-9F3F-8574498E87D8 Q36357766-5F0C9C44-2ECB-4C4E-9AEE-7B05435C1E94 Q36542254-E5628676-0688-4F43-9CCB-0B55066B9FEF Q36904739-05E28463-D1AC-43FC-80A9-70B75FF7688F Q37149062-251F0725-4BE5-4C8F-8D57-B11F7E7F3A90 Q37397803-F2E78F63-9CC4-4DCA-BD9C-C34836F46368 Q37462768-25B08E4B-B9AE-4668-9026-D53BCECA886F Q37691961-876D275E-DF3B-4887-AB6C-49FE4585008E Q37937344-649FFDF5-D9BB-4FA8-BA9F-692225DA3876 Q39408346-1C8F11D8-0F98-48D4-AC75-3063990C2EBD Q42537376-F1CA3C59-8974-48EF-9314-9CBBDD96189C Q42595723-A3CBA0C0-5543-4C66-B12A-7649FACD2FA4 Q42645301-9D2A3164-8389-4921-B900-DD79BD653D19 Q43694933-D702E76B-B37D-4FFE-A7C3-8D37F62AFBF1 Q43993276-639EAB13-13C4-4098-A5ED-0EDABA86CD26 Q47370738-6BDB119B-DA5E-459E-A0BC-57B1D3CB45F5 Q47662133-59111AAF-F756-4DED-86F9-F4C940B9BC3F

P2860

Markers of Cell Proliferation and Expression of Melanosomal Antigen in Lymphangioleiomyomatosis

http://www.wikidata.org/entity/Q55981835

description

article

@en

im September 1999 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 1999

@uk

ലേഖനം

@ml

name

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@en

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@nl

type

label

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@en

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@nl

prefLabel

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@en

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@nl

P1433

Q55981835-DD3C5E06-E705-4EB1-9AC1-5F2A83591639

P1476

Q55981835-B8853316-5243-4EB1-AA05-FAE476811B26

P2093

Q55981835-181B5A2F-7648-4395-86B3-59BC52397694

Q55981835-43BF0835-2FF6-4117-B58F-888BD8BD08E4

Q55981835-5D855674-7BE6-4AC1-8EFF-F12147927454

Q55981835-70013B9C-B40E-4138-824D-FBB0D0240C92

Q55981835-7B262D80-AE02-4F1C-86A2-C1C3583D8115

Q55981835-FBC79835-CBE4-4D4E-8AC5-A3C1473BEE9F

P2860

Q55981835-09E27318-5EC2-4348-81D7-2E6878589795

Q55981835-208661A7-F119-4553-B667-D89C492DEE99

Q55981835-20880CAD-041F-492B-BE9A-DE445CDC0E18

Q55981835-29C8C152-3F35-49E1-830C-9B96DD894C13

Q55981835-392543EF-56E6-4AC6-A92A-29D66447C83D

Q55981835-4AFB1CCE-F8C7-40CA-A008-4701288064E0

Q55981835-4BA6E066-9B31-4079-8C77-C0FD4E5F99C6

Q55981835-670B0DFB-D9DF-450D-967C-02F6681A6D69

Q55981835-86A67188-EEFB-448C-B94E-4B1E2358CA55

Q55981835-A7B982FD-8D06-4C60-8F52-1BF2B58257AD

P304

Q55981835-075AAFE6-64C4-46B0-BD15-91FDCAA57C94

P31

Q55981835-17D27C48-0B6C-4090-AFC8-AD9C8529EC36

P356

Q55981835-120C32AF-7B9F-4231-A4CA-59A2A0A2CEAF

P433

Q55981835-F58B7B63-6D7D-4250-A763-361F1AB7956C

P478

Q55981835-E8F4C260-8EAC-4D1D-8CDD-59CD95D900B3

P577

Q55981835-8CCCC4E5-AA64-42BF-BBDF-1F4C8ACBCCA1

P698

Q55981835-DB850968-B05B-48FC-B1CB-75C460D3AA38

P356

AJRCMB.21.3.3693

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Markers of Cell Proliferation ...... en in Lymphangioleiomyomatosis

@en

P2093

Jiro Usuki

http://www.w3.org/2001/XMLSchema#string

Joel Moss

http://www.w3.org/2001/XMLSchema#string

Koji Horiba

http://www.w3.org/2001/XMLSchema#string

Shan C. Chu

http://www.w3.org/2001/XMLSchema#string

Victor J. Ferrans

http://www.w3.org/2001/XMLSchema#string

Yutaka Matsumoto

http://www.w3.org/2001/XMLSchema#string

P2860

A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manif

The Z lattice in canine cardiac muscle.

HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein.

Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis.

Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors.

Lymphangioleiomyomatosis

Immunohistochemical Detection of Steroid Receptors in a Case of Pulmonary Lymphangioleiomyomatosis

P304

327-336

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/AJRCMB.21.3.3693

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10460750

http://www.w3.org/2001/XMLSchema#string